A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Summary

To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).

Timeline

Start

2010-07-27

Primary completion

2012-09-24

Completion

2013-04-23

Outcome

Met primary endpoint

registry MEAN Ferumoxytol: 2.6 (Standard Deviation 1.55) g/dL NCT01114217 ↗

registry analysis (other test); Ferumoxytol; p <0.0001; t-test, 2 sided NCT01114217 ↗

Publications

• Background Vadhan-Raj S, Ford DC, Dahl NV, Bernard K, Li Z, Allen LF, Strauss WE. Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study. Am J Hematol. 2016 Feb;91(2):E3-5. doi: 10.1002/ajh.24240. No abstract available.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ferumoxytol	Diagnostic / imaging agent	510 mg	Intravenous

Indications